Munis Assad, Omar Hina, Iwaz Suzanne, Mahdavian Mani
Department of Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, IL.
Division of Gastroenterology, Advocate Lutheran General Hospital, Park Ridge, IL.
ACG Case Rep J. 2018 Nov 28;5:e80. doi: 10.14309/crj.2018.80. eCollection 2018.
Cholangiocarcinoma is a rare clinical entity representing approximately 2% of all cancers diagnosed. More than 65% of these tumors can present at the bifurcation of the hepatic duct and are known as Klatskin tumors. Pancreatic cancer is among the top 5 leading causes of cancer death, and it usually presents at an advanced stage with metastasis commonly seen in the liver. We report a patient with established pancreatic adenocarcinoma who presented with an obstructing mass at the hepatic duct bifurcation without any prior history of biliary tract disease. This represents a new diagnosis of either intracholedochal metastatic tumor or a new diagnosis of cholangiocarcinoma found at the hepatic duct bifurcation without liver involvement in the setting of pancreatic cancer, suggesting metachronous cholangiocarcinoma with pancreatic adenocarcinoma.
胆管癌是一种罕见的临床疾病,约占所有确诊癌症的2%。其中超过65%的肿瘤发生在肝管分叉处,被称为克氏壶腹周围癌。胰腺癌是癌症死亡的五大主要原因之一,通常在晚期出现,常见肝转移。我们报告一例确诊为胰腺腺癌的患者,该患者在肝管分叉处出现阻塞性肿块,既往无任何胆道疾病史。这代表了一种新的诊断,即胆总管内转移性肿瘤,或者是在胰腺癌背景下,肝管分叉处发现的无肝脏受累的胆管癌新诊断,提示为异时性胆管癌合并胰腺腺癌。